Inhibition of STAT3 phosphorylation by colchicine regulates NLRP3 activation to alleviate sepsis-induced acute lung injury
- 28 April 2023
- journal article
- research article
- Published by Springer Nature in Inflammopharmacology
- Vol. 31 (4) , 2007-2021
Abstract
The pharmacotherapeutic mechanism of colchicine, a tricyclic, lipid-soluble alkaloid extracted from the plant of the Lily family Colchicum autumnale, has not been fully understood in diverse disorders, including sepsis-induced acute lung injury (ALI). The study aimed at exploring the impact of colchicine on sepsis-induced ALI and the relevant mechanisms. Colchicine significantly attenuated ALI in mice caused by sepsis by alleviating respiratory dysfunction and pulmonary edema in mice, inhibiting NLRP3 inflammasome formation, and reducing oxidative stress, pyroptosis, and apoptosis of murine alveolar macrophage (J774A.1) cells. The targets of colchicine were predicted in the superPRED database and intersected with the differentially expressed genes in the GSE5883 and GSE129775 datasets. The major targets were subjected to protein–protein interaction network generation and Kyoto Encyclopedia of Genes and Genomes enrichment analysis. It was thus found that colchicine inhibited STAT3 phosphorylation but did not alter STAT3 total protein expression. Phosphorylated STAT3 recruited EP300 to form a complex to promote histone H3 acetylation and histone H4 acetylation of NLRP3 promoter, leading to pyroptosis of J774A.1 cells. In conclusion, inhibition of STAT3 phosphorylation by colchicine represses NLRP3 promoter acetylation via the STAT3/EP300 complex, thereby alleviating ALI caused by sepsis.Keywords
Funding Information
- National Natural Science Foundation of China (81770080)
- Xiangya Hospital-Beida Weiming Clinical Rehabilitation Research Fund (XYWM2015I20)
- Ministry of Science and Technology of the People's Republic of China (2016YFC1304204)
- Peking Union Medical Foundation - Ruiyi Emergency Medical Research Fund (R2021004)
- Hainan Provincial Medical and Health Research Project (20A200340)
This publication has 26 references indexed in Scilit:
- Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activationClinical Science, 2016
- Sepsis: pathophysiology and clinical managementBMJ, 2016
- Colchicine—Update on mechanisms of action and therapeutic usesSeminars in Arthritis and Rheumatism, 2015
- Diverse macrophage populations mediate acute lung inflammation and resolutionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2014
- Lung injury induced by sepsis: lessons learned from large animal models and future directions for treatmentExpert Review of Anti-infective Therapy, 2011
- Colchicine Modulates Oxidative Stress in Serum and Neutrophil of Patients with Behçet Disease Through Regulation of Ca2+ Release and Antioxidant SystemThe Journal of Membrane Biology, 2011
- Krüppel-Associated Box-Associated Protein 1 Negatively Regulates TNF-α–Induced NF-κB Transcriptional Activity by Influencing the Interactions among STAT3, p300, and NF-κB/p65The Journal of Immunology, 2011
- Histone Deacetylase Inhibitors Attenuate Acute Lung Injury During Cecal Ligation and Puncture‐Induced Polymicrobial SepsisWorld Journal of Surgery, 2010
- Gout-associated uric acid crystals activate the NALP3 inflammasomeNature, 2006
- Synergistic Signaling in Fetal Brain by STAT3-Smad1 Complex Bridged by p300Science, 1999